NCT06480916 Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation
| NCT ID | NCT06480916 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Régional Metz-Thionville |
| Condition | Maternal-Fetal Relations |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-04-01 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman cared for in a participating maternity unit * Over 18 years of age * Requested for maternal-fetal transfer (finally performed, or not) Exclusion Criteria: * missing data on transfer outcome
Contact & Investigator
Laetitia HONORE-ROUGE, MD
PRINCIPAL INVESTIGATOR
CHR Metz Thionville Hopital Femme Mère Enfant
Frequently Asked Questions
Who can join the NCT06480916 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Maternal-Fetal Relations. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06480916 currently recruiting?
Yes, NCT06480916 is actively recruiting participants. Contact the research team at projet-recherche-clinique@chr-metz-thionville.fr for enrollment information.
Where is the NCT06480916 trial being conducted?
This trial is being conducted at Briey, France, Châlons-en-Champagne, France, Metz, France, Romilly-sur-Seine, France and 4 additional locations.
Who is sponsoring the NCT06480916 clinical trial?
NCT06480916 is sponsored by Centre Hospitalier Régional Metz-Thionville. The principal investigator is Laetitia HONORE-ROUGE, MD at CHR Metz Thionville Hopital Femme Mère Enfant. The trial plans to enroll 500 participants.